Season 4 Episode 20: Cancer Immunotherapy Month

The PQI Podcast

This month, we celebrate Cancer Immunotherapy and its impact on people's lives. In our season 4 finale episode of The PQI Podcast, we have the privilege of sitting down with Mary Elizabeth Williams, who shares her inspiring story of overcoming metastatic melanoma and advocating for better access to clinical trials. Mary Elizabeth, a courageous stage 4 metastatic melanoma survivor, participated in a groundbreaking Phase 1 immunotherapy trial at Memorial Sloan Kettering. She became one of the pioneering individuals to receive nivolumab, a cutting-edge treatment. Just three months into the trial, her remarkable progress showed no signs of disease. Join us as we delve into her journey, highlighting the transformative potential of immunotherapy.

For the past several years, Mary Elizabeth has been chronicling her adventures with Stage 4 melanoma and working toward a better healthcare experience for all of us. She is a doctoral student of Medical Humanities at Drew University and has written for The New York Times, The Los Angeles Times, The Guardian, Salon, Time, and Health. Her recent book, A Series of Catastrophes and Miracles, A: A True Story of Love, Science, and Cancer, is on her experience with metastatic melanoma — and the groundbreaking immunotherapy clinical trial pioneered by Nobel winner James Allison — that saved her life. Her book can be found here.